Dose Comparison of Conivaptan (Vaprisol®) in Patients With Euvolemic or Hypervolemic Hyponatremia &Ndash; Efficacy, Safety, and Pharmacokinetics
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s95326
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Informa UK Limited